The World Health Organization (who) has approved the COVID-19 vaccine developed by India's Bharat Biotech laboratory for emergency use, it was announced. The drug is known worldwide under its commercial brand: Covaxin.
Brazil's Senatorial Committee (CPI), which is investigating the handling of the coronavirus pandemic, Thursday sent a letter to President Jair Bolsonaro asking him to address the allegations surrounding an obscure overpriced deal to purchase Covaxin immunizers.
The State Attorney's Office in Brasilia launched an enquiry into the alleged mishandlings by government officials regarding the acquisition of a supply of the Indian-made anticoronavirus Covaxin immunizer.
Brazil's National Health Surveillance Agency (Anvisa) Friday approves, albeit with some restrictions, imports of Covaxin and Sputnik V doses for use in up to 1% of the country's population, it was announced.
Brazil's health ministry on Thursday signed a deal with India's Bharat Biotech to purchase 20 million doses of Covaxin, a Covid 19 vaccine. The news came a day before Brazil marks one year since the first case of Covid-19 was confirmed in the country after a Sao Paulo businessman returning from a trip to Italy tested positive.